Flurry of Indian trial approvals offers hope, but uncertainty lingers
This article was originally published in Scrip
Executive Summary
India's health ministry is said to have cleared about 50 clinical studies after months of a near standstill in such approvals, though industry experts appear skeptical on the latest flurry of activity in the continued absence of clear processes and considering the upcoming Supreme Court hearing in a case concerning clinical trials.